共 50 条
- [31] USE OF NEOADJUVANT ANDROGEN DEPRIVATION THERAPY IN CLINICALLY LOCALIZED PROSTATE-CANCER CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1993, 16 (06): : 516 - 522
- [32] Should patients with localized prostate cancer receive primary androgen deprivation therapy? Nature Clinical Practice Urology, 2008, 5 : 648 - 649
- [34] INTERMITTENT ANDROGEN DEPRIVATION AS SECONDARY THERAPY FOR BIOCHEMICAL RECURRENCE OF LOCALIZED PROSTATE CANCER JOURNAL OF UROLOGY, 2011, 185 (04): : E142 - E143
- [35] Immediate versus deferred androgen-deprivation therapy for localized prostate cancer Nature Clinical Practice Urology, 2006, 3 (7): : 348 - 349
- [37] EARLY INDUCTION OF EPITHELIAL-TO-MESENCHYMAL TRANSITION FOLLOWING ANDROGEN DEPRIVATION IN PROSTATE CANCER CELLS IS SNAIL-DEPENDENT JOURNAL OF UROLOGY, 2012, 187 (04): : E132 - E133
- [38] EARLY INDUCTION OF EPITHELIAL-TO-MESENCHYMAL TRANSITION FOLLOWING ANDROGEN DEPRIVATION IN PROSTATE CANCER CELLS IS SNAIL-DEPENDENT JOURNAL OF UROLOGY, 2011, 185 (04): : E584 - E585
- [40] Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (01): : 24 - 28